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a  b  s  t  r  a  c  t
The  major  function  of  the enzyme  human  tissue  transglutaminase  (TG2)  is  the  crosslinking  of proteins
via  a transamidation  between  the  -carboxamide  of a glutamine  and  the  -amino  group  of  a lysine.
Overexpression  of  TG2  can  lead to  undesirable  outcomes  and  has been  linked  to conditions  such as  ﬁbrosis,
celiac disease  and  neurodegenerative  diseases.  Accordingly,  TG2  is  a tempting  drug  target.  The  most
effective  TG2  inhibitors  to  date  are  small-molecule  peptidomimetics  featuring  electrophilic  warheads
that  irreversibly  modify  the  active  site  catalytic  cysteine  (CYS277).  In  an  effort  to  facilitate  the  design
of  such  TG2  inhibitors,  we  undertook  a quantum  mechanical  reaction  proﬁling  of the  Michael  reaction
between  a set of  six  acrylamide-based  known  TG2  inhibitors  and  the TG2  CYS277.  The  inhibitors  were
docked  into  the  active  site and  the  coordinates  were  reﬁned  by  MD  simulations  prior  to modelling  the
covalent  modiﬁcation  of  the  CYS277  thiolate.  The  results  of  QM/MM  MD  umbrella  sampling  applied  to
reaction  coordinates  driving  the Michael  reaction  are  presented  for two  approximations  of  the  Michael
reaction:  a  concerted  reaction  (simultaneous  thiolate  attack  onto  the  acrylamide  warhead  and  pronation
from  the adjacent  HIS335)  and  a two-stage  reaction  (consecutive  thiolate  attack  and protonation).  The
two-stage  approximation  of the Michael  reaction  gave  the  better  results  for  the  evaluation  of  acrylamide-
based  potential  TG2  inhibitors  in  silico.  Good  correlations  were  observed  between  the experimental  TG2
IC50 data  and  the  calculated  activation  energies  over  the  range  0.0061–6.3  M (three  orders  of  magnitude)
and  we propose  that  this  approach  may  be  used  to  evaluate  acrylamide-based  potential  TG2  inhibitors.
© 2017  The  Authors.  Published  by Elsevier  Inc. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Human tissue transglutaminase, also known as transglutam-
nase 2 (TG2) is a member of the transglutaminase family of
nzymes. A major function of TG2 is the crosslinking of proteins via
 calcium-dependent transamidation between the -carboxamide
f a glutamine and an -amino group of a lysine [1]. Physiologi-
ally, TG2 activity is associated with regulation of the extracellular
atrix (ECM) formation, cell adhesion, wound healing, signal trans-
uction, apoptosis, and stabilisation of skin and hair [1–3].
Overexpression of TG2, however, can lead to undesirable out-
omes. For example, increased TG2 activity has been noted in
eurodegenerative diseases such as Parkinson’s, Alzheimer’s and
untington’s [4–6] as well as in celiac disease [7]. Furthermore,
he inhibition of TG2 activity has been shown to reduce metasta-
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sis in pancreatic and lung cancers [8,9]. Three of the major classes
of TG inhibitors that have been exempliﬁed include: competitive
reversible inhibitors such as cystamine [10,11]; reversible non-
competitive inhibitors that act by binding to an allosteric site within
TG2 preventing its activation [12,13]; irreversible inhibitors con-
taining an electrophilic warhead that act by alkylating the key
active site cysteine. (References given below) In the biological
setting, any inhibitor targeting the active site of TG2 has to over-
come the locally high total concentration of potential substrates,
for example competition with ﬁbronectin vitronectin, osteonectin,
osteopontin, laminin, ﬁbrillin, nidogen, collagens I, II V and XI in
the extracellular matrix [14]. For this reason, despite reservations
over potential toxicity and off-target activity, irreversible inhibitors
may, in the end, provide therapeutic inhibitors of this enzyme. Most
of the irreversible inhibitors published to date are peptidic or pep-
tidomimetic and contain an electrophilic group capable of reacting
with a cysteine thiolate anion, for example, maleimides, epoxides,
acrylamides, chloroacetamides, beta-keto sulfonium ions and sub-
stituted imadazolium groups [15–21].
Following on from a series of irreversible dipeptide-based
inhibitors (Fig. 1a) featuring the beta-keto sulfonium warhead [16],
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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eFig. 1. Irreversible TG2 inhibitor types and a ﬂ
he Grifﬁn group has published a set of conformationally-restricted
nhibitors (Fig. 1b) featuring the piperazinyl-glycylacrylamide core
tructure [15,21].
The piperazine portion serves to constrain the ﬂexibility of the
entral region of the compounds and the glycylacrylamide is able
o reach into the active site tunnel to allow a Michael reaction to
ccur between the thiolate anion of CYS277 and the beta carbon of
he acrylamide. The other piperazine nitrogen is bound to a series of
ydrophobic entities via amide, carbamate and sulfonamide link-
ges. In support of the presumed site of reaction for the acrylamide
ompounds being CYS277, the Grifﬁn group [15] has proﬁled a close
nalogue of acrylamide compound 5 (Table 1) featuring a beta-keto
ulfonium warhead in place of the acrylamide (Fig. 1(c)). Recom-
inant wild-type TG2 and its active site mutant CYS277SER were
ncubated with the compound. Subsequently, TG2 was  separated
n denaturing SDSPAGE and western blotted using an anti-dansyl
ntibody. The observed bands indicated that the inhibitor had been
ovalently incorporated into the wild-type enzyme but not the
YS277SER mutant form.
Our initial attempts to use computer-based protein-ligand
ocking methods (data not presented) to search for irreversible
nhibitors of TG2 were successful to the extent of distinguishing
etween moderate-high potency inhibitors and non-inhibitor ana-
ogues. It was not possible, however, to rank compounds according
o potency at the good-high potency end. In retrospect this is not
urprising, since in the case of irreversible covalent binding of the
nhibitor to the active site, placement of the inhibitor in the active
ite is only one part of the overall process. For example, it is pos-
ible for a compound to ﬁt very well into the active site but for
he subtleties of its arrangement in the active site to impair its
bility to derivatise the CYS277 thiolate anion. Therefore, as an
ttempt to develop a computational screening tool to allow the
anking of acrylamide-containing small molecules as irreversible
G2 inhibitors, we decided to implement a QM/MM  umbrella sam-
ling approach to investigate the covalent bond-forming stage.
hus the overall approach was to dock the potential inhibitors
nto the active site of a TG2 model, conduct MD  upon the com-
lexes, select plausible starting positions for an approximation to
he thiolate-acrylamide Michael reaction and to probe the energy
roﬁle of the reaction coordinate via umbrella sampling.
. Methods
MM-MD  simulations were performed using a CUDA-ported ver-
ion of Amber 12 [22–25] on workstations and servers equipped
ith Nvidia GTX 780, GTX 780 Ti or Titan graphics cards. QM MM-
D hybrid calculations [26,27] were performed using Amber 12 on
n Intel Xeon-based server. The trajectories were processed using
TRAJ or CPPTRAJ [28]. The production phases of all MD  trajecto-
ies were analysed with respect to temperature, pressure and RMSD
nd found to be stable.
.1. The inhibitorsSix irreversible TG2 inhibitors featuring an acrylamide warhead
ere used in this work (Table 1). They were adopted from Badarau
t al [15].cent example published by the Grifﬁn group.
2.2. Preparation of TG2 active site models and complexes
Our models for the open form of TG2 were derived from a
repaired version of the Protein Data Bank entry 2Q3Z [29] in which
the missing residues were added and the existing covalently-bound
inhibitor was deleted. CYS277 was set to its ionised form and
HIS335 was  allocated its protonated form following the gener-
ally accepted view that the catalytic triad CYS277, HIS335, ASP358
is arranged such that the cysteine and the histidine exist as
a thiolate-imidazolium pair stabilised by hydrogen bonding to
ASP358 [30,31]. In order to maximise the computational speed, the
sandwich and barrel domains at the furthest extremes of the pro-
tein structure (residues 1–154 and 586–683) were deleted. During
the course of an exploratory 250 ns MD simulation of the entire
enzyme in explicit water, the amino acid residues within 8 Å of
CYS277 were found to have an average RMSD of 0.82 Å using the
ﬁrst frame as a reference. Furthermore, the catalytic triad residues
CYS277, HIS335, ASP358 exhibited individual RMSF values of 0.38,
0.31 and 0.36 Å respectively. The same procedure applied to the
truncated enzyme resulted in an average RMSD of 0.92 Å and RMSF
values for CYS277, HIS335 and ASP358 of 0.33, 0.30 and 0.35 Å
respectively. This supported our view that the peripheral sandwich
and barrel domains were too far away from the active site core
region to have any effect upon the active site in the timescale of
the simulations reported in this work. These regions are identiﬁed
in yellow in Fig. S1a in the supplementary information.
The truncated version of the repaired enzyme was relaxed using
a combination of energy minimisation and molecular dynamics
(100 ns production phase) in explicit water using the Amber 12
package. Further details are given in the supplementary infor-
mation. Models for the active site were taken from the resultant
trajectory and probed by docking active TG2 irreversible inhibitors
taken from the work of Badarau et al. [14] and Grifﬁn et al. [16] using
the programs CACHe WorkSystem Pro (version 7.5.0.85, Fujitsu
Limited, Tokyo, Japan 2006) and GOLD Suite (version 5.2.2, CCDC
Software Limited, Cambridge, UK 2013) (ﬂexible ligand/ﬂexible
active site residue side chains). Six appropriate docking complexes
were selected on the basis of two  criteria: a maximum distance of
4 Å between the inhibitors’ warhead electrophilic carbon and the
CYS277 thiolate; the hydrophobic portion of the inhibitors being
satisfactorily buried under the helix 309 − 318 as seen in the crystal
structure 2Q3Z.pdb. The complexes were subjected to unrestrained
MD in explicit water for 275 ns from which 6 models of TG2 active
site were generated. The acrylamide-based inhibitors (1–6, Table 1)
were docked into the resulting active site models. Complexes for
these inhibitors were selected using the criteria given above and
these were subjected to a further 5 ns of molecular dynamics sim-
ulation at 300 K in explicit water.
The complexes that were carried through to the umbrella sam-
pling were either docked complexes from the penultimate stage
above (3, 4 and 6) or were snapshots from the ﬁnal 5 ns MD  simu-
lations (1, 2 and 5). For each compound, the structure selected was
the one that had the lowest distance between the thiolate sulfur
of CYS277 and the compound’s electrophilic carbon. Good dock-
ing rank and favourable interactions with active site residues (for
example, hydrogen bonding with GLN276, ASN333 and PHE334)
were also considered in the selection process.
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Table  1
Structures and IC50 values for the TG2 inhibitors used in this work [15].
Compound Structure TG2 IC50 (M)
1 0.125
2 0.44
3  6.3
4  2.1
5  0.0061
6  
Fig. 2. The distances D1, D2 and D3 together with , the angle of approach of the
t
d
t
u
d
formed by the attack of CYS277 thiolate upon the acrylamide ofhiolate nucleophile to the acrylamide carbon-carbon double bond.
These complexes were subjected to a further 5 ns molecular
ynamics simulation under the same conditions but with the addi-
ion of the two distance constraints D1 and D2, outlined in Fig. 2,
sing a force constant of 500 kcal/mol Å2 to maintain the initial
istances.1.625
This was followed by a 100 ps QM/MM  MD equilibration run
under constant pressure in TIP3P water. The quantum mechanical
(QM) region comprised the ligand, the side chain of CYS277 and the
protonated imidazole ring of HIS335. The rest of the system was
treated molecular mechanically using the ff99SB force ﬁeld [32]. In
addition, the distances D1 and D2 were restrained to their starting
values with a force constant of 50 kcal/mol Å2.
2.3. Exploration of the reaction coordinate
A study by Paasche et al. [33] indicated that ,-unsaturated
amides, unlike ,-unsaturated aldehydes, react with thiols pref-
erentially via thiolate attack onto the -carbon generating a
carbanion at the -position (“direct addition”) rather than placing
the negative charge on the carbonyl oxygen. The latter scenario
would involve a high-energy enolate structure arising from the
interruption of the natural tutomeric state of the acrylamide amide
group. Instead, the relatively lower-energy carbanion is then proto-
nated by any convenient proton source. Therefore, in order to model
the covalent modiﬁcation of TG2 CYS277 by the inhibitors 1–6,
we chose this direct addition pathway rather than the sequence
of enolate formation, protonation of the enolate oxygen and ﬁnally
base-catalysed reformation of the carbonyl group. The protonated
imidazole of HIS335, a constituent of the catalytic triad was chosen
as the most likely source for the protonation of the initial adductseach inhibitor. There was  no other protein-based proton source
near enough to be able to neutralise the negatively charged adducts.
For example, the nearest lysine -amino group or arginine side-
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Fig. 3. The approximation of the Michael reaction resulting in covalent modiﬁcation of CYS277: Step 1–thiolate attack on the -carbon of the acrylamide; Step 2–proton
transfer from HIS335 to the carbanion.
Table 2
Transition state parameters, activation energy (AE), reaction energy (RE) calculated at PM3/AMBERff99SB and the TG2 IC50 data for the six acrylamide compounds.
Compound D1 (Å) D2 (Å) RC (Å)  (◦) Dihedral (◦) AE (kcal/mol) RE (kcal/mol) IC50 (M)
1 1.83 2.06 3.89 98.3 56 42.55 6.66 0.125
2  1.94 1.61 3.54 111.5 72 29.57 8.70 0.44
3  2.15 1.71 3.85 94.5 61 69.71 29.66 6.3
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i4  1.96 1.91 3.87 114.7 
5  2.03 1.85 3.89 94.0 
6  1.83 1.63 3.46 110.7 
hain functionality was at least 9 Å from the required protonation
ite. Protonation via water molecules within the active site remains
 possibility but their number and proximity to the protonation
ite varied with each inhibitor adduct (and were entirely absent in
he simulations involving compounds 2 and 5) and thus it was  not
ossible to derive a uniﬁed approximation to the overall Michael
eaction that involved water molecules.
Two approximations of the “direct addition” Michael reac-
ion mechanism for the reaction were explored (Fig. 3). The ﬁrst
nvolved a single concerted stage only, during which a bond
etween the nucleophilic sulfur of CYS277 and the -carbon of the
crylamide was formed and the  H of the protonated imidazole
f HIS335 was transferred to the -carbon of the acrylamide. The
econd approximation of the Michael reaction ran these two events
onsecutively, starting with the thiolate nucleophilic attack.
.3.1. Umbrella sampling
Each simulation was initiated from the restart ﬁle at the end
f the 100 ps QM-MM  relaxation and two methods were used to
alculate the energy of the QM region: PM3  [27] and SCC-DFTB
34,35].
.3.1.1. Concerted reaction. For the single-stage concerted approxi-
ation of the Michael reaction, the reaction coordinate was  deﬁned
s a generalised distance coordinate involving the sum of distances
1 and D2 (Fig. 2). This reaction coordinate was set to change from
ts starting value to a value of 2.8 Å (≈1.8 Å for D1 and ≈1 Å for D2).
or compound 5 (the most active compound) the same concerted
rocess was also explored using the distances D1 (3.5–1.63 Å) and
2 (5.3–0.9 Å) as separate reaction coordinates and using PM3  as
he QM method.
.3.1.2. Stepwise reaction. For the two-stage approximation of the
ichael reaction, the reaction coordinate for the ﬁrst stage was  the
ingle distance D1 (ﬁnal value 1.6 Å) and the reaction coordinate for
he second step was deﬁned as a generalised distance coordinate
ampling D2 minus D3 (ﬁnal value −2 Å). Further details are given
n the supplementary information..3.2. Potential of mean force (PMF) calculations
The weighted histogram analysis method (WHAM) [36–38]
mplemented in the WHAM program [39] was used to calculate the87 40.44 17.57 2.1
80 35.66 −6.70 0.0061
73 63.19 49.69 1.625
potential of mean force (PMF) from the time proﬁles for the US sim-
ulations. The criteria for successful umbrella sampling simulations
were appropriate overlap between the windows of all the simula-
tions, the formation of the relevant new bonds and the fact that the
compound maintained its general pose within the TG2 active site
at the end of the simulation.
3. Results and discussion
3.1. Single-stage concerted approximation of the Michael reaction
Umbrella sampling simulations involving the generalised dis-
tance coordinate (D1 + D2) and SCC-DFTB as the QM method were
unable to drive the reaction to completion for compound 2. In
contrast, when PM3  was the applied QM method, all six simula-
tions completed to the assigned value of the reaction coordinate,
the two  bonds formed, the compounds maintained their original
pose within the TG2 active site and a sufﬁcient degree of over-
lap between the US windows was  observed. The PMF  values (PM3)
were calculated using the WHAM program and plotted against the
reaction coordinate for all six compounds (supplementary infor-
mation, Fig. S2). A similar path was  followed by all the compounds
during their US simulations and the barrier height was reached
at a similar value for the reaction coordinate in each case. The
time-courses of the relevant angles and atom-atom distances were
measured using the VMD  program [40]. These are given in the sup-
plementary information, Fig. S4. Across the compound set, D1 and
D2 declined together. The angle of approach of the attacking thio-
late () was observed to be between 94 and 115◦ at the transition
state, straddling the ideal Bürgi–Dunitz angle [41] of 107◦ for the
analogous nucleophilic attack on a carbonyl group. The dihedral
angle for the attacking thiolate trajectory was also measured. This
is described by the thiolate sulfur, the acrylamide -carbon, the
-carbon and the carbonyl carbon. At the transition state for the
six compounds, values were observed in the range 56–87◦. These
values, together with , indicated an appropriate approach of the
thiolate approximately orthogonal to the plane of the acrylamide.
After the S-C bond was formed,  assumed values appropriate for a
tetrahedrally-substituted carbon atom. The activation energy (AE)
was taken as the difference between the barrier height and the
energy of the reactants, the latter being zero in most cases, and
the reaction energy (RE) was  the energy difference between the
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tig. 4. Plot of activation energy Log(AE) against TG2 IC50 for compounds 1 − 6.
eactants and the products. The values of these parameters for the
ix inhibitors at the barrier heights are presented in Table 2. For
ompound 5, the 2-D free energy surface resulting from umbrella
ampling D1 and D2 as separate reaction coordinates gave very sim-
lar transition state parameters (distances, angles and charges) to
hose obtained from the umbrella sampling described above for the
eneralised distance coordinate D1 + D2, apart from the transition
tate energy itself. These properties are stated in the supplemen-
ary information in Table S1 together with the corresponding 2-D
ree energy surface expressed as a contour plot in Fig. S3.
The plot of AE against TG2 IC50 (Fig. 4) exhibited a trend of
ncreasing AE with decreasing biological activity with R2 = 0.56,
ising to 0.79 if the outlier compound 6 is removed. The reaction
nergies were less realistic in that they indicated that the covalent
odiﬁcation of CYS277 was endothermic in all cases except for the
ost potent inhibitor, compound 5. Nevertheless, inspection of the
eactions energies was able to rank ﬁve out of the six compounds
orrectly in terms of potency.
Thus the method was able to drive the reaction to completion
nd to produce activation energies that correlated roughly with
he biological activity. However, close inspection of the trajecto-
ies revealed a problem with the simulations involving compounds
, 3 and 5. In these cases the starting conﬁgurations placed the
YS277 thiolate and the HIS355 	-NH in close proximity. In the
arly stages of the umbrella sampling the positively-charged imi-
azole protonated the thiolate. This was conﬁrmed by monitoring
he charge on the sulfur atom which had changed from the initial
ull negative charge to approximately neutral. Under the inﬂuence
f the imposed reaction coordinate, the resulting CYS277-SH then
oved onto the inhibitor acrylamide alkene and completed the
arbon-sulfur bond formation and the proton transfer to carbon
ssentially simultaneously. In contrast, for compounds 2, 4 and 6,
he CYS277 thiolate and the HIS355 	-NH were not in close prox-
ig. 5. Plots of PMF  against RC for compounds 1–6 during the ﬁrst step (attack of the thiola
he  compound number) represent the TS position. The reaction proceeds from higher to lraphics and Modelling 79 (2018) 157–165 161
imity in the starting conﬁgurations. In the course of the umbrella
sampling the CYS277 thiolate retained its full negative charge until
the moment of sulfur-carbon bond formation. There followed a
period where the former acrylamide -carbon and the carbonyl
oxygen shared approximately one whole negative charge between
them. This is consistent with the expected delocalisation of the
charge across these atoms. Finally, the proton was transferred from
the positively-charged HIS355 to the -carbon of the former acry-
lamide of the inhibitor.
This lack of uniformity across the six inhibitors was the spur to
simulate the Michael reaction in a discrete two-stage process.
3.2. Consecutive two-stage approximation of the Michael reaction
Both SCC-DFTB and PM3-based calculations were successful
in driving both stages of the Michael reaction to completion and
resulted in plausible structures and no change in the ﬁnal position
of the inhibitor. As in the case of the single-stage concerted ver-
sion of the Michael reaction, the activation energy (AE) was taken
as the difference between the barrier height and the energy of the
reactants. For the PM3-based calculations, however, no meaningful
correlation could be made between biological activity and the cal-
culated activation energy. In contrast, SCC-DFTB-based calculations
yielded useful correlations. Therefore, only the results for SCC-DFTB
will be presented. A relatively high value of 250 kcal/mol Å2 for the
force constant was  necessary to drive the reactions to completion.
This is consistent with the work published by Silva et al. [42] who
used the same force constant whilst investigating the inhibition of
mycobacterial L,D-transpeptidase 2 by carbapenems. In that case
the process involved a similar nucleophilic attack of an active site
cysteine thiolate upon the carbonyl carbon atom of a carbapenem.
A proton was transferred in the second step from a nearby histidine
residue to saturate the resulting amino nitrogen.
3.2.1. First stage: attack of the thiolate anion
At the end of this simulation stage, the new S-C bond was  present
for all the inhibitors and the ﬁnal conformations were used as the
starting points for the second stage. The calculated PMF  plots are
shown in Fig. 5. In each case a saddle was observed in the region
of RC = 2 Å. This was selected to be the TS corresponding to the ﬁrst
stage.
For the six inhibitors, the structures at the saddle points had
very similar values for D1 and  and the values of  and the
dihedral angle indicated an appropriate approach of the thiolate
approximately orthogonal to the plane of the acrylamide. Along
the reaction coordinate, the charge on the CYS277 thiolate was
observed to change from the initial full negative charge to a value
around −0.5 at the saddle point. These transition state parameters
are summarised in Table 3 along with the PMF  activation ener-
te anion to give a carbanion-containing product as shown). The markers (containing
ower RC values.
162 M.H. Jasim, D.L. Rathbone / Journal of Molecular Graphics and Modelling 79 (2018) 157–165
Table 3
Transition state parameters for ﬁrst stage (thioate attack; calculated at SCC-
DFTB/AMBERff99SB) of the two-stage approximation of the Michael reaction.
Compound D1 (Å)  (◦) Dihedral (◦) Charge S AE (kcal/mol)
1 2.08 114 84 −0.49 25.67
2  1.99 114 64 −0.40 17.45
3  2.03 114 57 −0.55 32.61
4  2.01 124 80 −0.59 25.61
5  2.11 120 63 −0.53 19.68
6  1.96 113 76 −0.48 22.95
F
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Fig. 8. Plot of Log(AE) against TG2 IC50 for the 2nd stage (protonation) of the 2-stage
simulations for acrylamide compounds 1 − 6.
Table 4
Transition state parameters for the second stage (protonation; calculated at SCC-
DFTB/AMBERff99SB) of the two-stage approximation of the Michael reaction using
DFTB  as the QM method.
Comp. RC (Å) D2 (Å) D3 (Å) Charge O Charge
-C
AE
(kcal/mol)
1 0.85 1.94 1.10 −0.72 −0.60 134.27
2  0.70 1.80 1.09 −0.57 −0.57 107.95
3  0.85 1.91 1.11 −0.70 −0.56 209.74
iting step [43]. In the present case with the simulation of the TG2
inhibitory action of compounds 1–6, it happens that the approach of
F
rig. 6. Plot of Log(AE) against TG2 IC50 for the 1st stage (thiolate attack) of the
-stage simulations for acrylamide compounds 1 − 6.
ies at that point for each compound. The latter showed reasonable
orrelation with TG2 IC50 with an R2 of 0.63 (Fig. 6).
.2.2. Second stage: proton transfer from HIS335 to the ˛-carbon
f the former acrylamide
The method was able to drive this stage to completion and the
rotonation of the -carbon was evident for all the compounds.
he overlap between the US windows achieved was  reasonable
lthough the windows were apparent in the WHAM-generated PMF
lots in the shape of curves corresponding to each window (Fig. 7).
or each compound, the highest point on the curve in the RC range
–0 was taken to be the transition state or the barrier height for the
econd stage. It is represented in Fig. 7 by markers containing the
ompound numbers.
The TS structures occurred over RC values 0.4–1.1 Å. In all
ases, at the TS, HIS335 remained protonated. The charges on the
crylamide carbonyl oxygen and the -carbon indicated that the
egative charge was delocalised over these atoms. The activation
nergy for the 2nd stage (protonation) correlated well with biolog-
cal activity with an R2 of 0.80 (Fig. 8). The TS parameters are given
n Table 4.
ig. 7. PMF  graphs of the 6 compounds for the 2nd stage of the 2-stage US simulations
epresent the TS position. The reaction proceeds from higher to lower RC values.4  0.34 1.48 1.09 −0.62 −0.56 150.15
5  1.13 2.19 1.06 −0.65 −0.61 92.24
6  0.48 1.63 1.03 −0.67 −0.56 137.73
3.2.3. Charge time proﬁle across the two stages of simulation and
the relative activation energies
As can be seen from Fig. 9 the time courses of charge variation
on the key atoms in the reaction centre (CYS277 sulfur, the acry-
lamide carbonyl oxygen and -carbon) were similar across all six
compounds when viewed for steps one and two combined. In each
case as the ﬁrst stage progressed, the charges on the -carbon and
the carbonyl oxygen became more negative, reaching their most
negative by the end of the ﬁrst stage. Simultaneously, the full neg-
ative charge on the cysteine sulfur moderated to approximately
−0.3. This is consistent with the negative charge being passed from
the sulfur to be delocalised across the -carbon and the carbonyl
oxygen. The activation energy values for the ﬁrst stage (the for-
mation of the sulfur-carbon bond) were lower than those for the
second stage (the protonation step) suggesting that the latter is the
rate limiting step for this reaction. This is in contrast to the tra-
ditional view for a small-molecule thiol Michael addition reaction
where the attack of the thiolate is considered to be the rate lim-the acrylamide warhead to the CYS277 thiolate is energetically eas-
ier than the distortion of the protein necessary to allow HIS355 to
 using DFTB as the QM method. The markers (containing the compound number)
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fig. 9. The time courses of the charges on the CYS277 sulfur, the acrylamide carbon
he  charge. The vertical line marks the end of the 1st step.
erform the second stage protonation. An alternative proton source
ay  have been better in this regard, but, as mentioned earlier, the
nly other possibility would be a water molecule and for two of the
imulations (compounds 2 and 5) there were no water molecules
resent in the active site..2.4. Distance time proﬁle across the two stages of simulation
The time proﬁle of the key atom-atom distances (D1, D2 and D3)
ollowed very similar patterns across the compound set and weregen and -carbon. The X-axis has the simulation time in ps and the Y-axis records
under the control of the reaction coordinates of the two stages at
all times. This is exempliﬁed in Fig. 10 for compound 6 where the
distance time course is given for both stages of simulation.
4. ConclusionGood or reasonable correlations were observed between
the TG2 IC50 data and the activation energies for ﬁrst stage
(thiolate attack; R2 0.63), the second stage (protonation; R2
164 M.H. Jasim, D.L. Rathbone / Journal of Molecular G
Fig. 10. Key atom-atom distance time course for the simulation of compound 6. The
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Comp. Phys. Comm. 184 (2013) 374–380, http://dx.doi.org/10.1016/j.cpc.
2012.09.022.ertical line marks the end of the ﬁrst stage.
.89) but less so for the single-stage approach (combined thi-
late attack and protonation; R2 0.56). In light of this it
ppears that under the conditions of the assay [44], the cova-
ent modiﬁcation of the active site cysteine is rate-limiting
ompared with the generation of the initial protein-inhibitor com-
lex. In each of the six piperazinylglycylacrylamide-based TG2
nhibitors considered in this study, the point of variation was
he hydrophobic aryl/adamantly substituent with its associated
mide/carbamate/sulphonamide link to the piperazine core. The
ffect of these substituents in the protein-ligand docking exper-
ments and subsequent molecular dynamics simulations was to
nchor the inhibitors slightly differently in the TG2 active site
articularly with respect to the exact location of the acrylamide
arhead relative to the CYS277 thiolate. That in turn gave rise to
he differences in the activation energies observed for the imposed
eaction coordinates. Furthermore, the positioning of the warhead
n the active site tunnel did not allow the presence of active-site
ater molecules for the simulations involving compounds 2 or
 and for the other compounds interaction with water was lim-
ted, there being respectively 1, 1, 2 and 1 water molecules making
ydrogen bonding contact with the CYS277 thiolate anion for the
imulations involving compounds 1, 3, 4 and 6. It is therefore highly
nlikely that desolvation of the thiolate anion is a major concern on
he reaction pathway for the inhibitory action of these compounds.
his is in contrast to the work of Capoferri et al. [45], who studied
he Michael-type direct addition of an acrylamide-based inhibitor
o the solvent-accessible CYS797 of epidermal growth factor recep-
or at the SCC-DFTB/AMBER99SB level. In that case desolvation of
he thiolate anion was the key step of the overall process rather than
he carbon-sulfur bond formation and subsequent protonation of
he transient carbanion.
Overall, this approximation of the thiolate Michael reaction
s a reasonable approach for the evaluation of acrylamide-based
otential TG2 inhibitors in silico: Protein-ligand docking combined
ith molecular dynamics and biochemically-relevant selection
riteria were observed to be enough to weed out the non-
otent compounds. Thereafter, the QM/MM  MD umbrella sampling
pproaches described above were able to provide a reasonable cor-
elation between activation energies and TG2 IC50 over the range
.0061–6.3 M (three orders of magnitude) for use with compound
anking.
ppendix A. Supplementary dataSupplementary data associated with this article can be found, in
he online version, at https://doi.org/10.1016/j.jmgm.2017.10.012.raphics and Modelling 79 (2018) 157–165
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